Trial Profile
Darunavir total and unbound plasma concentrations in darunavir/ritonavir-treated patients with hepatic cirrhosis and HIV and hepatitis C coinfection, compared with HIV monoinfected patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Darunavir/ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 16 Dec 2015 New trial record